<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00696605</url>
  </required_header>
  <id_info>
    <org_study_id>Swiss AVP-Copeptin Trial</org_study_id>
    <nct_id>NCT00696605</nct_id>
  </id_info>
  <brief_title>Assessment of Circulating Copeptin Levels in Healthy Subjects and Patients With Renal Insufficiency After Oral Water Load and Hypertonic Saline Infusion</brief_title>
  <official_title>Assessment of Circulating Copeptin Levels in Healthy Subjects and Patients With Renal Insufficiency After Oral Water Load and Hypertonic Saline Infusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Centre Biel/Bienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brahms AG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Centre Biel/Bienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The are 2 principal goals in this study:

        1. To measure plasma copeptin levels in healthy subjects and to correlate them with plasma
           AVP concentrations and urine osmolalities in iso-, hypo-, and hyperosmolar states.

        2. To measure plasma copeptin concentrations in patients with chronic renal failure under
           the same conditions described above, in order to characterize the impact of renal
           function on circulating copeptin levels in correlation to plasma AVP and urine
           osmolality.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">20</enrollment>
  <condition>Hypoosmolality</condition>
  <condition>Hyperosmolality</condition>
  <condition>Renal Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy volunteers; patients with chronic renal failure
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  chronic renal failure grade I through IV

          -  healthy age-matched controls

        Exclusion Criteria:

          -  chronic renal failure grade V

          -  heart failure

          -  liver disease

          -  nephrotic syndrome

          -  anemia (hemoglobin level &lt; 100 g/L)

          -  uncontrolled hypertension (systolic BP &gt; 160 mmHg; diastolic BP &gt; 95 mm Hg)

          -  coexisting severe disease

          -  known thyroid disease

          -  known hypocortisolism

          -  known hypercortisolism

          -  known diabetes insipidus

          -  pregnancy

          -  lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinic of Internal Medicine, Hospital Center</name>
      <address>
        <city>Biel/Bienne</city>
        <zip>2501</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2008</study_first_submitted>
  <study_first_submitted_qc>June 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2008</study_first_posted>
  <last_update_submitted>February 23, 2017</last_update_submitted>
  <last_update_submitted_qc>February 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Centre Biel/Bienne</investigator_affiliation>
    <investigator_full_name>Jonas Rutishauser</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Hypoosmolality</keyword>
  <keyword>Hyperosmolality</keyword>
  <keyword>Copeptin</keyword>
  <keyword>Vasopressin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Diabetes Insipidus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arginine Vasopressin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

